The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.00
Bid: 110.00
Ask: 111.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.909%)
Open: 114.50
High: 114.50
Low: 109.50
Prev. Close: 111.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Jan 2024 07:00

RNS Number : 7455Z
McBride PLC
16 January 2024
 

16 January 2024

 

McBride plc

 

Trading Update

 

Continuing shift to private label value supporting good trading activity.Financial performance slightly ahead of our expectations.

 

McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2023 ("the Period").

 

The Group expects to report first half adjusted operating profit slightly ahead of our expectations.

 

Group revenue was 9.9% higher than the prior year on a constant currency basis, benefitting from both volume growth and the impact of pricing actions in the last financial year to recover input cost inflation. Overall volumes in the Period were 6.4% higher, driven by continuing momentum in private label (private label volumes grew by 10.1%) as consumers continue to mitigate cost of living pressures.

 

While input costs have generally stabilised, energy, employment and financing costs continue to apply inflationary pressures. Additionally, the Group continues to manage significant supply chain volatility.

 

The Group's focus on reducing debt and maintaining tight control of costs resulted in net debt closing the Period at £145.7m (30 June 2023: £166.5m), with liquidity at £85.0m (30 June 2023: £59.3m), comfortably above the minimum requirement per the banking covenant. The Group continues to anticipate that net debt / adjusted EBITDA will be close to 2x by 30 June 2024.

 

The Group's half-year results will be announced on 27 February 2024.

 

 

 

 

McBride plc

0161 203 7570

Chris Smith, Chief Executive Officer

Mark Strickland, Chief Financial Officer

 

 

Instinctif Partners

Guy Scarborough

Bryn Woodward

 

0207 457 2020

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulations which came into effect on 3 July 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQELFFZFLBBBK
Date   Source Headline
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting
25th Aug 20224:40 pmRNSResult of AGM
22nd Aug 20223:41 pmRNSHolding(s) in Company
15th Aug 20225:48 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSNotice of General Meeting
14th Jul 20227:00 amRNSFull year trading update
29th Jun 20227:00 amRNSJune 2022 - Bank Covenant Waiver
17th Jun 20224:42 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
9th Jun 20221:55 pmRNSDirector/PDMR Shareholding
24th May 20223:20 pmRNSDirector/PDMR Shareholding
23rd May 202212:31 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20221:19 pmRNSDirector/PDMR Shareholding
18th Mar 202210:05 amRNSDirector/PDMR Shareholding
7th Mar 202210:03 amRNSDirector/PDMR Shareholding
28th Feb 20225:47 pmRNSDirector/PDMR Shareholding
24th Feb 20225:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSHalf-year Report
18th Feb 20227:00 amRNSBoard Changes
22nd Dec 20213:02 pmRNSDecember 2021 - Bank Covenant Waiver
16th Dec 20217:00 amRNSFinancial Year 2022 Trading Update
26th Nov 20219:48 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSRedemption of B Shares
8th Nov 20212:02 pmRNSDirector/PDMR Shareholding
26th Oct 20213:01 pmRNSDirector/PDMR Shareholding
26th Oct 20212:21 pmRNSDirector/PDMR Shareholding
26th Oct 20211:35 pmRNSDirector/PDMR Shareholding
19th Oct 20216:05 pmRNSResult of AGM
19th Oct 20217:00 amRNSAGM Trading Update
7th Oct 20213:05 pmRNSDirector/PDMR Shareholding
5th Oct 20216:21 pmRNSCorrection to the Annual Report
30th Sep 20216:16 pmRNSRedemption of B Shares
24th Sep 20217:00 amRNSAnnual Report 2021 and Annual General Meeting 2021
13th Sep 20213:27 pmRNSDirector/PDMR Shareholding
7th Sep 20214:05 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSFinal Results
2nd Sep 20215:00 pmRNSTransaction in Own Shares
1st Sep 20215:29 pmRNSTransaction in Own Shares
31st Aug 20215:14 pmRNSTransaction in Own Shares
25th Aug 20215:18 pmRNSTransaction in Own Shares
24th Aug 20215:09 pmRNSTransaction in Own Shares
23rd Aug 20215:33 pmRNSTransaction in Own Shares
20th Aug 20215:00 pmRNSTransaction in Own Shares
19th Aug 20215:49 pmRNSTransaction in Own Shares
19th Aug 20217:00 amRNSFinancial Year 2022 trading update
14th Jul 20217:00 amRNSFull year trading update
9th Jul 20211:27 pmRNSReplacement: Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.